Asuman Celikbilek

Asuman Celikbilek

Auto-generated profile, based on publicly available information

Asuman Celikbilek

Department of Neurology, University of Health Sciences, Sincan Training and Research Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2013 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
ACAsuman Celikbilek
Asuman Celikbilek
SISevda Ismailogullari
Sevda Ismailogullari
GZGokmen Zararsiz
Gokmen Zararsiz

15 August 2014 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
HBHasan Ali Bayhan
Hasan Ali Bayhan
SBSeray Aslan Bayhan
Seray Aslan Bayhan
ACAsuman Celikbilek
Asuman Celikbilek
NTNermin Tanık
Nermin Tanık
CGCanan Gürdal
Canan Gürdal

1 August 2018 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
ACAsuman Celikbilek
Asuman Celikbilek
MCMehmet Celikbilek
Mehmet Celikbilek
GBGurbet Bozkurt
Gurbet Bozkurt
Objective: The aim of this study was to investigate cognitive performance for the first time in participants with nonalcoholic fatty liver disease (NAFLD) using the Montreal Cognitive Assessment (MoCA). Participants and methods: In total, 70 participants with NAFLD and 73 age-matched and sex-matched healthy participants were enrolled in this prospective cross-sectional study. The diagnosis of NAFLD was made on the basis of abdominal ultrasonography findings. Anthropometric indices were calculated, and routine laboratory analyses were carried out for each participant. All participants provided sociodemographic data and completed the Beck Depression Inventory-II. Cognitive functions were evaluated using the Turkish version of the MoCA, with a cut-off score for mild cognitive impairment of less than 21 points. Results: The MoCA scores were significantly lower in participants with NAFLD than in the healthy group (P<0.05). In addition, more NAFLD participants than healthy participants presented with deficits in the visuospatial (P<0.05) and executive function domains (P<0.05). In the multivariate model, education level [2.79 (1.12–6.96); P<0.05] and area of residence [5.68 (2.24–14.38); P<0.001] were associated independently with cognitive dysfunction in both the NAFLD and the healthy groups. The MoCA scores were correlated negatively with fibrosis 4 scores in NAFLD participants (r=−0.359; P0.05). Conclusion: Our results show that NAFLD patients may have early or subtle cognitive dysfunction, including in the visuospatial and executive function domains, as indexed by scores on the MoCA test. Further targeted psychometric testing will be required to confirm the presence of cognitive impairment in this population.

20 May 2014 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
ACAsuman Celikbilek
Asuman Celikbilek
AGAyse Yesim Gocmen
Ayse Yesim Gocmen
NTNermin Tanik
Nermin Tanik
EBElif Borekci
Elif Borekci
MAMehmet Adam
Mehmet Adam
NDNamik Delibas
Namik Delibas

18 May 2014
Verified
Journal Article
Closed access
ACA. Celikbilek
A. Celikbilek
AGA. Y. Gocmen
A. Y. Gocmen
GZG. Zararsiz
G. Zararsiz
NTN. Tanik
N. Tanik
HAH. Ak
H. Ak
NDN. Delibas
N. Delibas
Inflammation is proposed to be involved in the pathogenesis of both vitamin D deficiency and migraine. However, the data examining the relation of vitamin D with migraine are limited. We aimed to investigate the serum levels of vitamin D, vitamin D-binding protein (VDBP) and vitamin D receptor (VDR) in combination, in migraine patients from central Anatolia region. Fifty-two newly diagnosed migraine patients and age- and sex-matched 49 control subjects were enrolled in this cross-sectional prospective study. Migraine diagnosis was settled according to the International Classification of Headache Disorders-II diagnostic criteria. Serum samples were analysed for the measurement of vitamin D, VDBP and VDR levels by using commercial enzyme-linked immuno sorbent assay kits. Serum vitamin D and VDR levels were found to be significantly lower in migraine patients than in controls (p = 0.012 and p = 0.038, respectively); whereas serum VDBP levels were similar between the groups (p > 0.05). There was no correlation between serum vitamin D, VDBP and VDR levels and headache characteristics including aura, attack severity, frequency and duration, and disease duration (p > 0.05). In terms of headache characteristics, no significant difference between migraineurs with vitamin D values < 25 and ≥ 25 ng/ml was observed (p > 0.05). The present findings may suggest that decreased serum vitamin D levels were associated with migraine.

19 August 2013 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
ACA. Celikbilek
A. Celikbilek
ZGZ. K. Gencer
Z. K. Gencer
LSL. Saydam
L. Saydam
GZG. Zararsiz
G. Zararsiz
NTN. Tanik
N. Tanik
MOM. Ozkiris
M. Ozkiris